Clinical Trial

6 Weeks Right-Amygdala TIS for Depression

Completed
View on ClinicalTrials.gov →
Summary
The current investigation employs a directed neuromodulation technique, specifically targeting the right amygdala, to ascertain its therapeutic efficacy in managing depressive episodes. The intervention's safety and efficacy will be evaluated using an assessment incorporating depressive symptomatology, cognitive abilities, and daily functions.
Protocol Amendment History 4 changes
critical Trial status changed: Enrolling by Invitation → Completed 2026-07-10
notable Enrollment reduced: 50 -> 38 participants 2026-07-10
notable Primary completion moved earlier: 2026-12-31 -> 2026-05-29 2026-07-10
minor Completion moved earlier: 2026-12-31 -> 2026-07-08 2026-07-10
Trial Details
NCT Number NCT07059143
Lead Sponsor Ruijin Hospital
Conditions Major Depressive Disorder (MDD)
Enrollment 38 participants
Start Date 2025-05-27
Primary Completion 2026-05-29 (estimated)
Study Completion 2026-07-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-09